DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 97 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $37,217,000 | -31.4% | 3,481,471 | -2.1% | 3.02% | -14.3% |
| Q3 2018 | $54,275,000 | +23.0% | 3,556,669 | -1.2% | 3.53% | +8.1% |
| Q2 2018 | $44,112,000 | +28.1% | 3,600,954 | 0.0% | 3.26% | +27.2% |
| Q1 2018 | $34,425,000 | +4.3% | 3,600,954 | -1.5% | 2.57% | -25.8% |
| Q4 2017 | $33,020,000 | +1542.0% | 3,656,669 | +1392.5% | 3.46% | +976.6% |
| Q3 2015 | $2,011,000 | -41.2% | 245,000 | 0.0% | 0.32% | -29.3% |
| Q2 2015 | $3,418,000 | -16.3% | 245,000 | +44.1% | 0.45% | -28.1% |
| Q1 2015 | $4,085,000 | +24.0% | 170,000 | -15.0% | 0.63% | +24.2% |
| Q4 2014 | $3,294,000 | – | 200,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |